These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 529342)

  • 1. Interspecies comparison of carcionogenic potency.
    Crouch E; Wilson R
    J Toxicol Environ Health; 1979 Nov; 5(6):1095-118. PubMed ID: 529342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
    Johnson FM
    Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On interspecies correlations of carcinogenic potencies.
    Kodell RL; Basu AP; Gaylor DW
    J Toxicol Environ Health; 1996 Jun; 48(3):231-7. PubMed ID: 8656447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database.
    Gold LS; Slone TH; Ames BN
    Drug Metab Rev; 1998 May; 30(2):359-404. PubMed ID: 9606609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of carcinogenicity from two versus four sex-species groups in the carcinogenic potency database.
    Gold LS; Slone TH
    J Toxicol Environ Health; 1993 May; 39(1):143-57. PubMed ID: 8492327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further development of a multifactor potency scheme for chemical carcinogens.
    Nesnow S
    Cancer Detect Prev; 1995; 19(6):465-71. PubMed ID: 8925515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
    Sanner T; Dybing E; Willems MI; Kroese ED
    Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment.
    Proctor DM; Gatto NM; Hong SJ; Allamneni KP
    Toxicol Sci; 2007 Aug; 98(2):313-26. PubMed ID: 17426108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemicals classified by IARC: their potency in tests for carcinogenicity in rodents and their genotoxicity and acute toxicity.
    McGregor DB
    IARC Sci Publ; 1992; (116):323-52. PubMed ID: 1428089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some tautologous aspects of the comparison of carcinogenic potency in rats and mice.
    Bernstein L; Gold LS; Ames BN; Pike MC; Hoel DG
    Fundam Appl Toxicol; 1985 Feb; 5(1):79-86. PubMed ID: 3987994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogenicity of bromodichloromethane administered in drinking water to Male F344/N Rats and B6C3F1 mice.
    George MH; Olson GR; Doerfler D; Moore T; Kilburn S; DeAngelo AB
    Int J Toxicol; 2002; 21(3):219-30. PubMed ID: 12055023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic bioassays: relevance to quantitative risk assessment of carcinogens.
    Rieth JP; Starr TB
    Regul Toxicol Pharmacol; 1989 Oct; 10(2):160-73. PubMed ID: 2813869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.